Insider Transactions in Q4 2023 at Immuno Gen, Inc. (IMGN)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2023
|
Stacy Ann Coen SVP & CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
367
+0.57%
|
$5,872
$16.01 P/Share
|
|
Dec 29
2023
|
Stacy Ann Coen SVP & CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+32.21%
|
$150,000
$5.32 P/Share
|
|
Dec 29
2023
|
Mark Alan Goldberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
569
+0.93%
|
$16,501
$29.65 P/Share
|
|
Dec 29
2023
|
Renee Lentini VP & PRIN ACCTG OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
467
+4.98%
|
$7,472
$16.01 P/Share
|
|
Dec 29
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
BUY
Grant, award, or other acquisition
|
Direct |
615
+15.22%
|
$9,840
$16.01 P/Share
|
|
Dec 29
2023
|
Michael Vasconcelles EVP R&D & MEDICAL AFFAIRS |
BUY
Grant, award, or other acquisition
|
Direct |
1,327
+50.0%
|
$21,232
$16.01 P/Share
|
|
Dec 29
2023
|
Helen M. Thackray Director |
BUY
Grant, award, or other acquisition
|
Direct |
252
+7.58%
|
$7,308
$29.65 P/Share
|
|
Dec 29
2023
|
Stuart A Arbuckle Director |
BUY
Grant, award, or other acquisition
|
Direct |
442
+7.59%
|
$12,818
$29.65 P/Share
|
|
Dec 26
2023
|
Renee Lentini VP & PRIN ACCTG OFFICER |
SELL
Open market or private sale
|
Direct |
6,548
-43.65%
|
$189,892
$29.74 P/Share
|
|
Dec 22
2023
|
Renee Lentini VP & PRIN ACCTG OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
-
|
|
Dec 15
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
117,445
-97.66%
|
$3,405,905
$29.4 P/Share
|
|
Dec 15
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
117,445
+45.15%
|
$469,780
$4.94 P/Share
|
|
Nov 30
2023
|
Kristine Peterson Director |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$560,000
$28.9 P/Share
|
|
Nov 30
2023
|
Kristine Peterson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$220,000
$11.59 P/Share
|
|
Nov 30
2023
|
Stacy Ann Coen SVP & CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
3,826
-10.35%
|
$110,954
$29.2 P/Share
|
|
Nov 30
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
164,424
-98.32%
|
$4,603,872
$28.95 P/Share
|
|
Nov 30
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
164,424
+32.5%
|
$1,644,240
$10.72 P/Share
|
|
Nov 29
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
6,792
-70.73%
|
$108,672
$16.66 P/Share
|
|
Nov 29
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
6,792
+41.43%
|
$67,920
$10.65 P/Share
|
|
Nov 17
2023
|
Stacy Ann Coen SVP & CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
78,223
-67.91%
|
$1,251,568
$16.05 P/Share
|
|
Nov 17
2023
|
Stacy Ann Coen SVP & CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
78,223
+22.54%
|
$469,338
$6.31 P/Share
|
|
Nov 16
2023
|
Stacy Ann Coen SVP & CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
4,100
-9.98%
|
$65,600
$16.01 P/Share
|
|
Nov 16
2023
|
Stacy Ann Coen SVP & CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,100
+4.76%
|
$24,600
$6.31 P/Share
|
|
Nov 15
2023
|
Stacy Ann Coen SVP & CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
26,286
-41.56%
|
$420,576
$16.01 P/Share
|
|
Nov 15
2023
|
Stacy Ann Coen SVP & CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
26,286
+17.16%
|
$157,716
$6.31 P/Share
|
|
Nov 15
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
166,725
-98.34%
|
$2,500,875
$15.85 P/Share
|
|
Nov 15
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
166,725
+49.58%
|
$666,900
$4.55 P/Share
|
|
Nov 07
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
19,517
-87.41%
|
$312,272
$16.66 P/Share
|
|
Nov 07
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
19,517
+46.64%
|
$195,170
$10.65 P/Share
|
|
Nov 07
2023
|
Richard John Wallace Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$140,000
$14.7 P/Share
|
|
Nov 06
2023
|
Renee Lentini VP & PRIN ACCTG OFFICER |
SELL
Open market or private sale
|
Direct |
219,545
-100.0%
|
$3,293,175
$15.29 P/Share
|
|
Nov 06
2023
|
Renee Lentini VP & PRIN ACCTG OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
120,528
+8.91%
|
$843,696
$7.05 P/Share
|
|
Oct 30
2023
|
Mark Alan Goldberg Director |
SELL
Exercise of conversion of derivative security
|
Direct |
10,000
-14.26%
|
$150,000
$15.08 P/Share
|
|
Oct 30
2023
|
Mark Alan Goldberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.48%
|
$140,000
$14.7 P/Share
|
|
Oct 16
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
192,004
-98.56%
|
$2,688,056
$14.4 P/Share
|
|
Oct 16
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
192,004
+32.09%
|
$768,016
$4.55 P/Share
|